Although not well defined in the kidney, dysregulation of Th17 cells or IL-17 signaling causes pathology in other autoimmune conditions, such as psoriasis and psoriatic arthritis, where anti–IL-17 biologics are now standard therapies (18, 19). This evidence concerns the gene IL17A and psoriatic arthritis.